Cargando…

Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae

PURPOSE: Fluoroquinolones are recommended for the treatment of pneumonia. The recognition of risk factors for invasive levofloxacin-resistant Streptococcus pneumoniae is important for the design of treatment. METHODS: A retrospective review of cases of invasive pneumococcal infections in adults was...

Descripción completa

Detalles Bibliográficos
Autores principales: Isea-Peña, M. C., Sanz-Moreno, J. C., Esteban, J., Fernández-Roblas, R., Fernández-Guerrero, M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102337/
https://www.ncbi.nlm.nih.gov/pubmed/23709294
http://dx.doi.org/10.1007/s15010-013-0481-4
_version_ 1783511804037562368
author Isea-Peña, M. C.
Sanz-Moreno, J. C.
Esteban, J.
Fernández-Roblas, R.
Fernández-Guerrero, M. L.
author_facet Isea-Peña, M. C.
Sanz-Moreno, J. C.
Esteban, J.
Fernández-Roblas, R.
Fernández-Guerrero, M. L.
author_sort Isea-Peña, M. C.
collection PubMed
description PURPOSE: Fluoroquinolones are recommended for the treatment of pneumonia. The recognition of risk factors for invasive levofloxacin-resistant Streptococcus pneumoniae is important for the design of treatment. METHODS: A retrospective review of cases of invasive pneumococcal infections in adults was undertaken. Epidemiologic data, predisposing factors, clinical variables, and outcome were recorded from previously established protocols. Antimicrobial susceptibility was determined by disk diffusion and the Etest method. Serotyping was performed by latex agglutination and Quellung reaction. RESULTS: Twenty patients with infection caused by levofloxacin-resistant pneumococci [minimum inhibitory concentration (MIC) ≥2 μg/ml] were compared with 102 patients harboring levofloxacin-susceptible strains; 80 % of levofloxacin-resistant pneumococci were resistant to ≥3 antibiotics but susceptible to penicillin. Most levofloxacin-resistant strains (80 %) belonged to serotype 8. In comparison, only 8 % of levofloxacin-susceptible pneumococci belonged to serotype 8. In the multivariate analysis, residence in public shelters [odds ratio (OR) 26.13; p 0.002], previous hospitalization (OR 61.77; p < 0.001), human immunodeficiency virus (HIV) infection (OR 28.14; p = 0.009), and heavy smoking (OR 14.41; p = 0.016) were associated with an increased risk of infection by levofloxacin-resistant pneumococci. Mortality caused by levofloxacin-resistant and levofloxacin-susceptible pneumococci was 35 and 14 %, respectively. Among HIV-positive individuals infected with levofloxacin-resistant pneumococci 44 % died, but only 12.5 % of HIV-positive patients with levofloxacin-susceptible strains died. CONCLUSIONS: We observed the emergence of serotype 8 as the main cause of invasive disease caused by levofloxacin-resistant S. pneumoniae. HIV-positive patients seem to be prone to infection caused by multidrug-resistant serotype 8 and have a high mortality rate.
format Online
Article
Text
id pubmed-7102337
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71023372020-03-31 Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae Isea-Peña, M. C. Sanz-Moreno, J. C. Esteban, J. Fernández-Roblas, R. Fernández-Guerrero, M. L. Infection Clinical and Epidemiological Study PURPOSE: Fluoroquinolones are recommended for the treatment of pneumonia. The recognition of risk factors for invasive levofloxacin-resistant Streptococcus pneumoniae is important for the design of treatment. METHODS: A retrospective review of cases of invasive pneumococcal infections in adults was undertaken. Epidemiologic data, predisposing factors, clinical variables, and outcome were recorded from previously established protocols. Antimicrobial susceptibility was determined by disk diffusion and the Etest method. Serotyping was performed by latex agglutination and Quellung reaction. RESULTS: Twenty patients with infection caused by levofloxacin-resistant pneumococci [minimum inhibitory concentration (MIC) ≥2 μg/ml] were compared with 102 patients harboring levofloxacin-susceptible strains; 80 % of levofloxacin-resistant pneumococci were resistant to ≥3 antibiotics but susceptible to penicillin. Most levofloxacin-resistant strains (80 %) belonged to serotype 8. In comparison, only 8 % of levofloxacin-susceptible pneumococci belonged to serotype 8. In the multivariate analysis, residence in public shelters [odds ratio (OR) 26.13; p 0.002], previous hospitalization (OR 61.77; p < 0.001), human immunodeficiency virus (HIV) infection (OR 28.14; p = 0.009), and heavy smoking (OR 14.41; p = 0.016) were associated with an increased risk of infection by levofloxacin-resistant pneumococci. Mortality caused by levofloxacin-resistant and levofloxacin-susceptible pneumococci was 35 and 14 %, respectively. Among HIV-positive individuals infected with levofloxacin-resistant pneumococci 44 % died, but only 12.5 % of HIV-positive patients with levofloxacin-susceptible strains died. CONCLUSIONS: We observed the emergence of serotype 8 as the main cause of invasive disease caused by levofloxacin-resistant S. pneumoniae. HIV-positive patients seem to be prone to infection caused by multidrug-resistant serotype 8 and have a high mortality rate. Springer Berlin Heidelberg 2013-05-25 2013 /pmc/articles/PMC7102337/ /pubmed/23709294 http://dx.doi.org/10.1007/s15010-013-0481-4 Text en © Springer-Verlag Berlin Heidelberg 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical and Epidemiological Study
Isea-Peña, M. C.
Sanz-Moreno, J. C.
Esteban, J.
Fernández-Roblas, R.
Fernández-Guerrero, M. L.
Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae
title Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae
title_full Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae
title_fullStr Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae
title_full_unstemmed Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae
title_short Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae
title_sort risk factors and clinical significance of invasive infections caused by levofloxacin-resistant streptococcus pneumoniae
topic Clinical and Epidemiological Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102337/
https://www.ncbi.nlm.nih.gov/pubmed/23709294
http://dx.doi.org/10.1007/s15010-013-0481-4
work_keys_str_mv AT iseapenamc riskfactorsandclinicalsignificanceofinvasiveinfectionscausedbylevofloxacinresistantstreptococcuspneumoniae
AT sanzmorenojc riskfactorsandclinicalsignificanceofinvasiveinfectionscausedbylevofloxacinresistantstreptococcuspneumoniae
AT estebanj riskfactorsandclinicalsignificanceofinvasiveinfectionscausedbylevofloxacinresistantstreptococcuspneumoniae
AT fernandezroblasr riskfactorsandclinicalsignificanceofinvasiveinfectionscausedbylevofloxacinresistantstreptococcuspneumoniae
AT fernandezguerreroml riskfactorsandclinicalsignificanceofinvasiveinfectionscausedbylevofloxacinresistantstreptococcuspneumoniae